✦ LIBER ✦

70PD EFFECT OF ENOBOSARM, A SELECTIVE ANDROGEN RECEPTOR MODULATOR, IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH MUSCLE WASTING IN A PHASE IIB TRIAL

✍ Scribed by Croot, C.C.; Johnston, M.A.; Steiner, M.S.; Hancock, M.L.; Somer, B.G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enobosarm, a selective androgen receptor

✍ Taylor⁎, R.; Hancock, M.; Johnston, M.; Steiner, M. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 67 KB

A phase I trial of gefitinib and nimotuz

✍ Kim, Se Hyun; Shim, Hyo Sup; Cho, Jaeho; Jeong, Jae Heon; Kim, Sun Mi; Hong, Yun 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 275 KB

A phase II trial of radiochemotherapy wi

✍ Bischoff, H.G.; Latz, D.; Schraube, P.; Manegold, C.; Drings, P.; Wannenmacher, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 270 KB

A phase II trial of oral UFT plus cispla

✍ Saito, Junichi; Nakai, Yushi; Saijo, Yasuo; Nukiwa, Toshihiro; Koinumaru, Sadahi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Management of chemotherapy in elderly pa

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Phase II trial of MTA (AlimtaTM) and cis

✍ Shepherd, F.A; Arnold, A; Neville, A; Dancey, J; Rusthoven, J; Fisher, B; Eisenh 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB